Schedule 13G ownership disclosure

CYTOSORBENTS CORP

Common Stock · CUSIP: 23283X206

Event date: 2024-12-31

Filing-level shares
2,781,622.00
Percent of class
5.1%
  • Skylands Capital, LLC

    Shares: 2,781,622.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001821268-25-000003
Form type
SCHEDULE 13G
Filer
Cytosorbents Corp
CIK
CIK 1175151
Filed
Jan 07, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub